Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
08/05/2023 24:37
May 8 (Reuters) - Shin Nippon Biomedical Laboratories Ltd 2395.T :
* COMMENCEMENT OF TENDER OFFER FOR SATSUMA PHARMACEUTICALS, INC IN U.S.
* TENDER OFFER PRICED AT $0.91 PER SHARE IN CASH FOR SATSUMA
PHARMACEUTICALS, INC
IN U.S.
Source text for Eikon: ID:nTSqg8874a
Further company coverage: 2395.T
Recent news on Satsuma Pharmaceuticals
See all newsBrief: Satsuma Pharmaceuticals Announces FDA Acceptance Of 505(B)(2) NDA For Sts101, A Novel And Investigational Dihydroergotamine Nasal Powder Product For The Acute Treatment Of Migraine
Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
Brief: Satsuma Pharmaceuticals Says Received Letter Notifying Co Regained Compliance With Nasdaq
U.S. STOCKS ON THE MOVE-Alphabet Inc, BlackRock, Moderna
Satsuma Pharma soars on buyout deal from Japan's Shin Nippon